Barrioga, Khezil Mae S.
HRN: 24-48-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2024
CEFUROXIME 500MG (TAB)
02/13/2024
02/20/2024
PO
500mg
BID
S/p NSVD
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes